Effects of a vasopressin antagonist in women with dysmenorrhea

Lil Valentin, Povilas Sladkevicius, H. Kindahl, A. Broeders, Karel Marsal, P. Melin

Research output: Contribution to journalArticlepeer-review

Abstract

We compared menstrual pain, uterine contractility and blood circulation, and plasma concentrations of vasopressin and prostaglandin F(2alpha) metabolite in women with versus without primary dysmenorrhea, and determined the effects of a vasopressin antagonist, 1-deamino-2-D-Tyr(OEt)-4-Thr-8-Orn-oxytocin (Atosiban), on these parameters. Our results do not support the contention that vasopressin is involved in the etiology of dysmenorrhea, plasma concentrations of vasopressin being similar in dysmenorrheic women and controls, and the vasopressin antagonist Atosiban having no effect on menstrual pain, intrauterine pressure or uterine artery pulsatility index in dysmenorrheic women.
Original languageEnglish
Pages (from-to)170-177
JournalGynecologic and Obstetric Investigation
Volume50
Issue number3
DOIs
Publication statusPublished - 2000

Subject classification (UKÄ)

  • Gynaecology, Obstetrics and Reproductive Medicine

Fingerprint

Dive into the research topics of 'Effects of a vasopressin antagonist in women with dysmenorrhea'. Together they form a unique fingerprint.

Cite this